HealthBlawg

David Harlow's Health Care Law Blog

    • Twitter
    • Facebook
    • LinkedIn
    • RSS
    • Email
  • About
  • Archives
  • Podcast
  • Press
  • Awards/Reviews
  • HIPAA
  • HCSM

Hospital Readmission Data for All Payors

April 24, 2014

Efforts to reduce hospital readmissions have been focused on a handful of diagnoses and on government payors (primarily Medicare). In order to get a handle on the roughly 15% of the U.S. health care spend that goes to readmissions, it is vital to have a better understanding of what these readmissions are for, who is experiencing them, and why. Not every readmission is a preventable readmission — though health reform wonks are pretty highly focused on preventable readmissions for specific diagnoses (starting with acute myocardial infarction, heart failure and pneumonia).

Here's the data from 2011, thanks to HCUP (the Healthcare Utilization and Cost Project) at AHRQ:

  • In 2011, there were approximately 3 million adult hospital readmissions in the United States, and they were associated with about $41.3 billion in hospital costs.
  • For Medicare patients, the three conditions with the largest number of readmissions were congestive heart failure (134,500 readmissions), septicemia (92,900 readmissions), and pneumonia (88,800 readmissions). These conditions resulted in about $4.3 billion in hospital costs.
  • For Medicaid patients, the three conditions with the largest number of readmissions were mood disorders (41,600 readmissions), schizophrenia (35,800 readmissions), and diabetes (23,700 readmissions). These conditions resulted in about $839 million in hospital costs.
  • For the privately insured, the three conditions with the largest number of readmissions were maintenance chemotherapy (25,500 readmissions), mood disorders (19,600 readmissions), and complications of surgical or medical care (18,000 readmissions). These conditions resulted in about $785 million in hospital costs.

This statistical brief includes data on the top ten principal diagnoses for the original hospital stay, for each payor type, which is useful information to have at hand when discussing whether readmissions are preventable. We shouldn't be dinging hospitals for readmissions that are not preventable. Some situations are clear-cut; others are less so. Perhaps data sets like this will allow for more narrowly tailored policies and incentives to be developed in the future.

Conditions With the Largest Number of Adult Hospital Readmissions by Payer, 2011

David Harlow
The Harlow Group LLC
Health Care Law and Consulting

Filed Under: Health care policy, Health Law, Health Reform, Hospitals, Medicare, Value Based Purchasing

you might also like:

  1. Can Patient-Centered Care Reduce Hospital Readmissions?

  2. No pay for more never events: CMS proposes more never events and more hospital reporting obligations

  3. Leverage: Preventable readmissions and a recent OIG advisory opinion

« HIPAA Marketing Rule Guidance: Better Than Nothing
The Iceberg Waiting for Your Health Care Data »

Follow me on Twitter

David Harlow 💉😷 Follow 42,879 17,567

Mastodon @healthblawg@c.im #HealthCare #MedDevice #Compliance #Privacy @MyOmnipod #HIPAA #digitalhealth #HarlowOnHC #pinksocks Tweets are tweets No more no less

healthblawg
healthblawg avatar; David Harlow 💉😷 @healthblawg ·
6h 1618627492033531906

The latest Harlow On Health Care Daily #HarlowOnHC #digitalhealth #healthcare #innovation #privacy #hcldr Thx: @EricTopol @raeannephd @MobiHealthNews #digitalhealth #healthtech

Image for twitter card

It's time for banks to get more intelligent about artificial intelligence

americanbanker.com Artificial intelligence now has the potential to fundamentally change customers' relationships with banks...

paper.li

Reply on Twitter 1618627492033531906 Retweet on Twitter 1618627492033531906 0 Like on Twitter 1618627492033531906 0 Twitter 1618627492033531906
healthblawg avatar; David Harlow 💉😷 @healthblawg ·
7h 1618622524023095296

ICYMI> Stephen Sweriduk, CMO of Shields Health Care on the evolution of diagnostic imaging — Harlow on Healthcare https://healthblawg.com/2022/01/sweriduk-shields-healthcare.html?utm_source=twitter&utm_medium=social&utm_campaign=ReviveOldPost #digitalhealth #hcldr #hitsm

Image for the Tweet beginning: ICYMI>  Stephen Sweriduk, CMO Twitter feed image.
Reply on Twitter 1618622524023095296 Retweet on Twitter 1618622524023095296 0 Like on Twitter 1618622524023095296 0 Twitter 1618622524023095296
healthblawg avatar; David Harlow 💉😷 @healthblawg ·
14h 1618516629570174981

ICYMI> Jonathan Shannon, LexisNexis Risk Solutions, Talking Interoperability — Harlow on Healthcare https://healthblawg.com/2022/12/jonathan-shannon-lexisnexis.html?utm_source=twitter&utm_medium=social&utm_campaign=ReviveOldPost #digitalhealth #hcldr #hitsm

Image for the Tweet beginning: ICYMI>  Jonathan Shannon, LexisNexis Twitter feed image.
Reply on Twitter 1618516629570174981 Retweet on Twitter 1618516629570174981 1 Like on Twitter 1618516629570174981 1 Twitter 1618516629570174981
Load More
Follow me on Mastodon

HIPAAtools

Hipaatools

The HIPAA Compliance Toolkit

The Walking Gallery

The Walking Gallery

Quick Links

  • Home
  • Categories
  • Archives
  • Podcast Interviews
  • HIPAAtools
  • HIPAA Compliance
  • Health Care Social Media
  • Speaking
  • In the Press
  • Blogroll

David Harlow

David Harlow

HealthcareNOW Radio

Connect with David

  • Twitter
  • Facebook
  • LinkedIn
  • RSS
  • Email
  • Subscribe
  • Contact
  • Book Me: Speaking
  • About
  • The Harlow Group LLC
Copyright © 2006–2023
HealthBlawg is a publication of The Harlow Group LLC. See Copyright notice and disclaimer.
Fair use with attribution and a link is encouraged. Click for more on David Harlow.
[footer_backtotop text="Back to top" href="#"]